Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Merlin Biosciences Ltd

1.EARLYBIRD | Venture Capital   (49%):
Date Portfolio Exit September 2005 Esmertec AG www.esmertec.com IPO (SWX: ESMN) September 2005 Interhyp AG www.interhyp.de IPO (Prime Standard Frankfurt Exchange: IYP) April 2004 Element 5 AG www.element5.com Trade Sale to Digital River, Inc. (NASDAQ: DRIV) September 2003 kiwilogic.com AG www.kiwil...
2.EARLYBIRD | Venture Capital   (49%):
Datum Portfolio Exit September 2005 Esmertec AG www.esmertec.com IPO (SWX: ESMN) September 2005 Interhyp AG www.interhyp.de IPO (Prime Standard der Frankfurter B rse: IYP) April 2004 Element 5 AG www.element5.com Verkauf an Digital River, Inc. (NASDAQ: DRIV) September 2003 kiwilogic.com AG www.kiwi...
3.EVP - Portfolios by sector/country   (48%):
EVP II PORTFOLIO BY SECTOR HEALTHCARE Sector: Healthcare ColBar develops, manufactures and commercializes novel biosurgical products based on the company’s proprietary Glymatrix™ technology for the production of collagen-based matrices with programmed biodurability and long-term shape p...
4.EVP - Portfolios by sector/country   (48%):
EVP II PORTFOLIO BY COUNTRY GERMANY Sector: Communications Formed in January 2001, CoreOptics develops and manufactures subsystems for ultra high-speed optical networking applications. Their current portfolio includes 2 fully qualified, distortion tolerant 10Gbps and 40Gbps transponders for Metro, ...
5.European Investment Fund   (31%):
List of Investments Search Home Sitemap Contact </div About EIF Info & News Venture Capital Investment approach EIB Group resources EC Resources List of Investments ERP-EIF Dachfonds Portfolio Guarantees <A CLASS="netscape47" HREF="/highvap/" onMouseOver="window.status='High Value Added Produc...
6.GBS Venture Partners :: News and Events   (25%):
Melbourne researchers develop safer and more effective aspirin [18 Apr 2005 11:46] Monash University researchers and staff of the Melbourne-based biotechnology company Cerylid Biosciences Ltd, have discovered and developed a new class of anti-clotting drugs that appears to be more effective than asp...
7.Cortical   (25%):
Welcome To Cortical Cortical is a Melbourne based drug discovery and development company, which was formed in 2003 around the work of Associate Professor Eric Morand of Monash University's Centre for Inflammatory Diseases, and Dr Magdy Iskander of Monash's Victorian College of Pharmacy . Cortical ha...
8.Cortical   (25%):
Welcome To Cortical Cortical is a Melbourne based drug discovery and development company, which was formed in 2003 around the work of Associate Professor Eric Morand of Monash University's Centre for Inflammatory Diseases, and Dr Magdy Iskander of Monash's Victorian College of Pharmacy . Cortical ha...
9.Cortical   (25%):
Welcome To Cortical Cortical is a Melbourne based drug discovery and development company, which was formed in 2003 around the work of Associate Professor Eric Morand of Monash University's Centre for Inflammatory Diseases, and Dr Magdy Iskander of Monash's Victorian College of Pharmacy . Cortical ha...
10.PEA: The Fund Raisers Roundup...04/01   (23%):
The Fund Raisers Roundup Editor’s Note: Every issue of The Private Equity Analyst features a section reporting on the formation of new private equity funds. The items focus on how much money the funds are raising, where it is coming from, and what the firms intend to do with it. The funds fall ...
11.GBS Venture Partners :: News and Events   (20%):
NEWS Sunshine Heart Quarterly In... Pharmaxis Ltd Announces Glo... CogState Announces Restruct... CogState Signs Agreement to... Enrolment Commenced in Arid... Novasys Medical Announces N... ASX Announcement - Clinica... Bronchitol Cystic Fibrosis ... Cortical Pty Ltd Presents M... CogState Signs Ag...
12.GBS Venture Partners :: Company Profile   (20%):
Funds Available Active Support Role Investment Record COMPANY PROFILE GBS Venture Partners (GBS) is a leading life science venture capital group resulting from a November 2002 management buyout of Rothschild Bioscience Managers Limited from NM Rothschild & Sons (Aust) Ltd. GBS invests in and adds va...
13.Bayer UK and Ireland - Pharmaceuticals and health care, crop and animal protection, polymers and chemicals   (20%):
At Bayer in the UK/Ireland regions, our business activities focus on healthcare, crop science, polymers and chemicals and reflect those of our parent company, Bayer AG , the worldwide diversified chemicals and healthcare group. Bayer Links Bayer Global Annual Report 2004 UK Internet Links Bayer Busi...
14.BCM Technologies : News & Events   (19%):
News & Events Archive: 10/03/2005 PharmaFrontiers Presents Positive Tovaxin(TM) Research at International Multiple Sclerosis Meeting 08/10/2005 PharmaFrontiers to Present Tovaxin(TM) Research at International Multiple Sclerosis Meeting 07/25/2005 BCM Technologies president named to board of bioscie...
15.Kenson Ventures   (18%):
News Kenson News Alpha Innotech Angiogenix Arcturus AVIVA Biocompare BioForm BioKey DailyWellness Diagnostic Hybrids Epitomics Genetastix NewBiotics Optimer Pharmaceuticals Panomics Pepgen StemCyte SuperArray System Biosciences Vitra Bioscience VitaGenomics Home | Company | News | Investment | Portf...
16.Welcome to Ampersand Ventures | News   (17%):
Contact: Harry McBrien, Maier Advertising - harry@maier.com Phone: (860) 677-4581 Magellan Biosciences, Inc. Formed Through Combination of ESA and Dynex Combined Business Provides Broad Range of Products for Life Science Research and Clinical Diagnostics CHANTILLY, VA and CHELMSFORD, MA, Oct. 19, 20...
17.Apax Partners - Knowledge   (17%):
Apax Partners Registered Users Sitemap Contact Us Legal Home Sector Focus Tech & Telecom Team Investments Knowledge Retail & Consumer Team Investments Knowledge Media Team Investments Knowledge Healthcare Team Investments Knowledge Financial & Business Services Team Investments Knowledge Our Company...
18.MBBNet   (17%):
MBBNet Venture Capital, Business Service and Economic Development Organizations Minnesota Venture Capital Association National Association of Seed and Venture Funds National Venture Capital Association The VINE Venture Information Network for Entrepreneurs Venture Capital OnLine Yahoo! / Market Guid...
19.MBBNet on Health and Bio Technology Global Networks   (16%):
on Health and Bio Technology Global Networks      Advanced Medical Technology Association AdvaMed: Helpful Links [MBBNet]      Medical Device Manufacturers Association Links and Resources [MBBNet]      Company Directory [MBBNet] International Communicatio...
20.Abingworth - News   (16%):
News New anti-infectives company - Novexel - spun-out of the Sanofi-Aventis Group with 40M funding from Atlas-led VC group Paris, France, 03 December 2004 Read full article (external site) Inpharmatica successfully closes GBP13.9M (USD25M) third round financing London, UK, 08 November 2004 Read full...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others